The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Meyer, D. M.
Right arrow Articles by Carron, C. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meyer, D. M.
Right arrow Articles by Carron, C. P.

The Journal of Immunology, Vol 155, Issue 7 3578-3584, Copyright © 1995 by American Association of Immunologists


ARTICLES

Characterization of intercellular adhesion molecule-1 ectodomain (sICAM- 1) as an inhibitor of lymphocyte function-associated molecule-1 interaction with ICAM-1

DM Meyer, ML Dustin and CP Carron
Department of Immunology, Monsanto Company, St. Louis, MO 63198, USA.

Intercellular adhesion molecule-1 (ICAM-1) is a member of the Ig superfamily, contains five Ig-like domains comprising the extracellular portion of the molecule, and interacts with lymphocyte function- associated molecule-1 (LFA-1), a member of the beta 2-integrin family. LFA-1/ICAM-1 interaction is important in a variety of cellular events including Ag-specific T cell activation and leukocyte transendothelial migration. Recently, a soluble circulating form of ICAM-1 has been detected in human serum that appears to result from the proteolytic cleavage of membrane ICAM-1. Native and recombinant soluble forms of ICAM-1 have been reported to inhibit LFA-1/ICAM-mediated adhesion in vitro, and it is conceivable that circulating forms of soluble ICAM-1 are regulators of LFA-1/ICAM-1-mediated cell-cell interaction in vivo. We have investigated the properties of the ICAM-1 ectodomain (sICAM453) as an inhibitor of LFA-1 interaction with ICAM-1 in cell- and molecule- based systems. The results show clearly that recombinant sICAM453 can inhibit LFA-1/ICAM-1 interaction. Soluble ICAM-1 inhibited LFA-1- mediated cell adhesion to immobilized sICAM453 and homotypic T-cell aggregation with IC50 in the 20 to 40 microM range. Definitive evidence that sICAM-1 can inhibit LFA-1 interaction with ICAM-1 was obtained by showing that the sICAM-1 inhibited the interaction between LFA-1 protein micelles and ICAM-1 immobilized on plastic. These results clearly show that sICAM453 can bind to LFA-1 and competitively inhibit ICAM-1/LFA-1-mediated cell-cell interaction, albeit at concentrations much greater than found in plasma. As a consequence, it is unlikely that sICAM-1 would antagonize ICAM-1/LFA-1-mediated cellular events in vivo.


This article has been cited by other articles:


Home page
GlycobiologyHome page
V. I. Otto, E. Damoc, L. N. Cueni, T. Schurpf, R. Frei, S. Ali, N. Callewaert, A. Moise, J. A. Leary, G. Folkers, et al.
N-Glycan structures and N-glycosylation sites of mouse soluble intercellular adhesion molecule-1 revealed by MALDI-TOF and FTICR mass spectrometry
Glycobiology, November 1, 2006; 16(11): 1033 - 1044.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
C. Sonnet, P. Lafuste, L. Arnold, M. Brigitte, F. Poron, F. Authier, F. Chretien, R. K. Gherardi, and B. Chazaud
Human macrophages rescue myoblasts and myotubes from apoptosis through a set of adhesion molecular systems
J. Cell Sci., June 15, 2006; 119(12): 2497 - 2507.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. S. Angelov, P. Guillaume, M. Cebecauer, G. Bosshard, D. Dojcinovic, P. Baumgaertner, and I. F. Luescher
Soluble MHC-Peptide Complexes Containing Long Rigid Linkers Abolish CTL-Mediated Cytotoxicity
J. Immunol., March 15, 2006; 176(6): 3356 - 3365.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. I. Otto, T. Schurpf, G. Folkers, and R. D. Cummings
Sialylated Complex-type N-Glycans Enhance the Signaling Activity of Soluble Intercellular Adhesion Molecule-1 in Mouse Astrocytes
J. Biol. Chem., August 20, 2004; 279(34): 35201 - 35209.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
A.-M. Steff, D. Gagne, M. Page, P. Hugo, and D. Gosselin
Concentration of soluble intercellular adhesion molecule-1 in serum samples from patients with endometriosis collected during the luteal phase of the menstrual cycle
Hum. Reprod., January 1, 2004; 19(1): 172 - 178.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Weis, C. L. Schlichting, E. G. Engleman, and J. P. Cooke
Endothelial Determinants of Dendritic Cell Adhesion and Migration: New Implications for Vascular Diseases
Arterioscler. Thromb. Vasc. Biol., November 1, 2002; 22(11): 1817 - 1823.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
A.M. Mackler, L.M. Green, P.J. McMillan, and S.M. Yellon
Distribution and Activation of Uterine Mononuclear Phagocytes in Peripartum Endometrium and Myometrium of the Mouse
Biol Reprod, May 1, 2000; 62(5): 1193 - 1200.
[Abstract] [Full Text]


Home page
Obstet GynecolHome page
P. VIGANỎ, E. SOMIGLIANA, B. GAFFURI, R. SANTORSOLA, M. BUSACCA, and M. VIGNALI
Endometrial Release of Soluble Intercellular Adhesion Molecule 1 and Endometriosis: Relationship to the Extent of the Disease
Obstet. Gynecol., January 1, 2000; 95(1): 115 - 118.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
K. Kusterer, J. Bojunga, M. Enghofer, E. Heidenthal, K. H. Usadel, H. Kolb, and S. Martin
Soluble ICAM-1 reduces leukocyte adhesion to vascular endothelium in ischemia-reperfusion injury in mice
Am J Physiol Gastrointest Liver Physiol, August 1, 1998; 275(2): G377 - G380.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Kurkijarvi, D. H. Adams, R. Leino, T. Mottonen, S. Jalkanen, and M. Salmi
Circulating Form of Human Vascular Adhesion Protein-1 (VAP-1): Increased Serum Levels in Inflammatory Liver Diseases
J. Immunol., August 1, 1998; 161(3): 1549 - 1557.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.